Ticker Details
Sutro Biopharma, Inc.
IPO Date:	October 12, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$423.71M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 3.51%
Avg Daily Range (30 D):	$1.52 | 4.39%
Avg Daily Range (90 D):	$0.96 | 3.94%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	.27M
Avg Daily Volume (90 D):	.18M

Trade Size
Avg Trade Size (Sh.):	119
Avg Trade Size (Sh.) (30 D):	56
Avg Trade Size (Sh.) (90 D):	59

Institutional Trades
Total Institutional Trades:	682
Avg Institutional Trade:	$1.59M
Avg Institutional Trade (30 D):	$.89M
Avg Institutional Trade (90 D):	$1.12M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.63M
Avg Closing Trade (30 D):	$.71M
Avg Closing Trade (90 D):	$1.57M
Avg Closing Volume:	17.59K

News

Apr 19, 2026 @ 11:45 PM Sutro Biopharma Presents Promising Preclinical Dat... Source: Na

Feb 10, 2026 @ 12:00 PM Sutro Biopharma Announces Pricing of $110.0 millio... Source: Na

Dec 3, 2025 @ 1:00 PM Sutro Biopharma Announces First Cohort of Patients... Source: Sutro Biopharma

Nov 12, 2025 @ 3:00 PM Sutro Biopharma Highlights Next-Generation ADC Inn... Source: Sutro Biopharma

Nov 3, 2025 @ 1:00 PM Sutro Biopharma Announces Participation at the 16t... Source: Sutro Biopharma

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-24.53	$-2.94	$-20.78
Diluted EPS	$-24.53	$-2.94	$-20.78
Revenue	$99.61M	$14.52M	$11.65M
Gross Profit
Net Income / Loss	$-153.6M	$-38.48M	$-46.76M
Operating Income / Loss	$-119.51M	$-29.66M	$-38.05M
Cost of Revenue
Net Cash Flow	$-32.55M	$15.55M	$-7.8M
PE Ratio

Splits
Dec 03, 2025	1:10